DYLAN MOLENHOUR: Open Payments
NPI 1609631209 · CLAREMORE, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$723 in 36 payments from 7 companies in 2025. Trend: 2023 $0 · 2024 $520 · 2025 $723
Food & beverage: $723
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $388 |
| Teva Pharmaceuticals USA, Inc. | 3 | $153 |
| Neurocrine BioSciences, Inc. | 4 | $65 |
| Alkermes, Inc. | 2 | $38 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Vanda Pharmaceuticals Inc. | 2 | $31 |
| Lundbeck LLC | 1 | $15 |
Products named: VRAYLAR, AUSTEDO XR, INGREZZA, ARISTADA, REXULTI, FANAPT, ABILIFY MAINTENA.
Industry payments across OK — which companies pay providers there.
